Skip to main content
Equibles
THC logo

THC · Tenet Healthcare Corp · Metrics

Track THC — free

Use THC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research THC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$263.69 +0.23 (+0.09%) At close · Sep 11
S&P 400 member Russell 1000 member Rebalance outlook locked
Customer concentration — key customers 69% of revenue

Key customers — 69% of revenue (the year ended December 31, 2025)

“our top 10 managed care payers generated 69% of our managed care net patient service revenues for the year ended December 31, 2025.”

Key customers — 67% of receivables (At December 31, 2025)

“At December 31, 2025, 67% of our Hospital Operations segment's net accounts receivable was due from managed care payers.”
View the 10-K filed Feb 17, 2026
Market Cap
$21.06B
Shares
80.52M

THC metrics

82 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$263.46
Market cap
$21.06B

Price action

20 metrics
Price change (1W)
0.0%
Price change (30D)
-1.3%
Price change (3M)
+52.1%
Price change (6M)
+17.2%
Price change (YTD)
+32.6%
Price change (1Y)
+37.4%
Trailing year
Price change (5Y)
+262.3%
52-week high
$280.77
52-week low
$161.37
Change from 52-week high
-6.2%
Change from 52-week low
+63.3%
Annualized volatility
43.6%
Annualized volatility (3M)
52.6%
Beta
0.5
RSI (14D)
53.3
Price vs SMA 50
+8.8%
Price vs SMA 200
+25.9%
Avg volume (3M)
1.14M
Relative volume
0.6
Average dollar volume
$252.63M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
80.52M

Valuation

12 metrics
P / E (TTM)
10.2
Trailing earnings · reciprocal yield 9.8%
PEG ratio
0.0
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.0×
reciprocal yield 103.6%
P / book
4.5
reciprocal yield 22.1%
FCF yield
14.4%
TTM · current market cap
Buyback yield
7.8%
P / FCF
7.0
reciprocal yield 14.4%
P / operating cash flow
5.2
reciprocal yield 19.1%
Earnings yield
15.1%

Historical valuation

8 metrics
P / E historical average (3Y)
9.9×
reciprocal yield 10.1%
P / E historical average (5Y)
10.7×
reciprocal yield 9.4%
EV / revenue historical average (3Y)
1.2×
reciprocal yield 84.5%
EV / revenue historical average (5Y)
1.1×
reciprocal yield 87.8%
EV / EBIT historical average (3Y)
6.7×
reciprocal yield 14.9%
EV / EBIT historical average (5Y)
7.1×
reciprocal yield 14.0%
EV / EBITDA historical average (3Y)
5.4×
reciprocal yield 18.7%
EV / EBITDA historical average (5Y)
5.6×
reciprocal yield 18.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
7.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-24

Profitability

9 metrics
Gross margin
—
Operating margin
20.8%
Trailing 12 months
Net margin
14.6%
Gross profit (TTM)
—
Operating profit (TTM)
$4.54B
Net income (TTM)
$3.17B
Trailing 12 months
Diluted EPS (TTM)
$25.93
FCF margin
13.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+6.8%
Year over year
Net income growth YoY
+100.2%
Revenue (TTM)
$21.81B
Trailing 12 months
EPS growth YoY
+213.4%
Shares change YoY
-8.5%
Year over year · fewer shares
Revenue CAGR (3Y)
+3.6%
Revenue CAGR (5Y)
+3.9%
EPS CAGR (3Y)
+59.9%
EPS CAGR (5Y)
+32.8%
FCF CAGR (3Y)
+99.0%
FCF CAGR (5Y)
-2.5%

Quality

14 metrics
Return on equity
68.1%
Return on assets
10.3%
Debt / equity
—
Current ratio
1.4
EBITDA (TTM)
$5.43B
Free cash flow (TTM)
$3.02B
Quick ratio
1.3
Interest coverage
5.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$2.17B
Total assets
$30.68B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$4.01B
Capital expenditures (TTM)
$992.00M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$132.00M
R&D / revenue
—
Stock compensation / revenue
0.6%

Ownership (13F)

3 metrics
13F filers
684
13F filer change QoQ
-3
Institutional ownership
101.8%

Short interest

3 metrics
Short interest
2.3%
Latest settlement · 2.5 days to cover
Days to cover
2.5d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$44.19M
Insider-sentiment score
6 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 70318 CUSIP 88033G407 13F (30d) 255 filings 249 filers Visit website Investor relations